Potter E K, Mitchell L, McCloskey M J, Tseng A, Goodman A E, Shine J, McCloskey D I
School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.
Regul Pept. 1989 May;25(2):167-77. doi: 10.1016/0167-0115(89)90258-9.
The effects of neuropeptide Y (NPY) and related peptide fragments on blood pressure and vagal action at the heart were compared in the anaesthetized rat. A change in vagal action was taken as a measure of presynaptic activity and a change in blood pressure was taken as a measure of postsynaptic activity. NPY, NPY-(13-36), PYY-(13-36), des-Ser22-NPY-(13-36) and a stabilized 13-36 analogue of NPY (ANA NPY) all exerted pressor actions and attenuated vagal action at the heart. The maximum vagal inhibitory or presynaptic action in order of potency was NPY, ANA-NPY, PYY-(13-36) significantly greater than NPY-(13-36), des-Ser22-NPY-(13-36). The order of potency for the half time of this effect was NPY, ANA-NPY significantly longer than PYY-(13-36) and NPY-(13-36), which were significantly longer than des Ser22-NPY-(13-36). For the pressor or postsynaptic effects, NPY increased blood pressure significantly more and for a longer duration than all the 13-36 fragments, which were not demonstrably different in this respect. These results are consistent with the proposal that there are two populations of NPY receptors. The C-terminal flanking peptide of NPY (CPON) and desamido-NPY had no effect on either vagal action at the heart or on blood pressure.
在麻醉大鼠中比较了神经肽Y(NPY)及相关肽片段对血压和心脏迷走神经作用的影响。迷走神经作用的变化被用作突触前活动的指标,血压变化被用作突触后活动的指标。NPY、NPY-(13-36)、PYY-(13-36)、去丝氨酸22-NPY-(13-36)以及一种稳定的NPY 13-36类似物(ANA NPY)均能产生升压作用并减弱心脏的迷走神经作用。按效力顺序,最大的迷走神经抑制或突触前作用为NPY、ANA-NPY、PYY-(13-36),显著大于NPY-(13-36)、去丝氨酸22-NPY-(13-36)。这种作用半衰期的效力顺序为NPY、ANA-NPY,显著长于PYY-(13-36)和NPY-(13-36),而PYY-(13-36)和NPY-(13-36)又显著长于去丝氨酸22-NPY-(13-36)。对于升压或突触后效应,NPY使血压升高的幅度显著更大,且持续时间更长,而所有13-36片段在这方面无明显差异。这些结果与存在两种NPY受体群体的提议一致。NPY的C末端侧翼肽(CPON)和脱酰胺NPY对心脏的迷走神经作用或血压均无影响。